Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on April 9, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

FLUMAZENIL INJECTIO

Closed
SPE2DP-26-T-2784Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

This contract covers the procurement of Flumazenil Injection, a sterile, prescription-only intravenous medication supplied in 10 mL vials with a concentration of 0.1 mg/mL and a total strength of 1 mg per vial. The product is packaged in sets of 10 multiple-dose vials per unit package. The defined shelf life of the product is 24 months, with a requirement that no less than 21 months of shelf life remain at the time of receipt by the first government entity. The injection must be stored at controlled room temperature, between 20° to 25°C, and comply with strict medical labeling and packaging standards, including Medical Marking Standard No. 1A for identification and protection during shipping. The contract specifies delivery terms with a five-day delivery schedule to the destination point, Fort Bragg, with inspection and acceptance also at the destination. The procurement is tied to a solicitation number issued by the Department of Defense's Medical Supply Chain, ensuring compliance with applicable FDA regulations and Defense Logistics Agency packaging standards. The total quantity ordered under this contract is three unit packages, each containing 10 vials. All packaging must ensure product integrity throughout shipment, with the removal of government identification on any non-accepted supplies, adhering to the Defense Logistics Agency’s technical and quality requirements.

General Info

Procurement of Flumazenil Injection, 30 vials, 24-month shelf life, delivered to Fort Bragg.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

BLD A5474 PRATT ST, FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-2784.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA
Contacts

Full Description

Show more
FLUMAZENIL INJECTIO
FLUMAZENIL INJECTION, 0.1 MG PER ML<(>,<)>
.
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RX ONLY, STERILE, FOR INTRAVENOUS ADMINISTRATION ONLY.
.
EACH ML CONTAINS 0.1 MG OF FLUMAZENIL.
.
ROUTE: ,,,,,,,,,,INTRAVENOUS
DOSE FORM: ,,,,,,,,VIAL (ML)
STRENGTH:,,,,,,,,1 MG/10 ML
CONCENTRATION: ,,,,,,0.1 MG/ML
VIAL SIZE:,,,,,,,,10 ML
PACKAGE QUANTITY: ,,,,10 VIALS
.
UNIT OF ISSUE IS A PACKAGE CONTAINING 10 EACH (INDIVIDUALLY PACKAGED
MULTIPLE-DOSE VIALS).
.
TOTAL SHELF LIFE IS 24 MONTHS.
.
THERE SHALL BE A MINIMUM OF 21 MONTHS OF REMAINING SHELF LIFE
AT THE TIME OF RECEIPT BY THE FIRST GOVERNMENT ACTIVITY.
.
STORE AT 20° TO 25°C (68° TO 77°F)
[SEE USP CONTROLLED ROOM TEMPERATURE]
.
LABELING AND MARKING MUST IN ACCORDANCE WITH
MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013
.
2/27/2017
.
1 PG = 10 EA
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
SPE2DP-26-T-2784
SECTION B
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
HIKMA PHARMACEUTICALS USA INC. 32655 P/N NDC00143-9783-10
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7015982974 0001 PG 3.000
NSN/MATERIAL:6505013548591
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-354-8591 Quantity: 3 PG Purchase Request: 7015982974QTY: 3 Delivery: 5 days ADO

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS